Efficacy of venetoclax combined with homoharringtonine and cytarabine for younger adults with newly diagnosed AML
Sign Up to like & getrecommendations! Published in 2025 at "Annals of Hematology"
DOI: 10.1007/s00277-025-06250-z
Abstract: Venetoclax (VEN)--based induction therapy has demonstrated considerable promise in treating acute myeloid leukemia (AML); however, the optimal VEN-based combination therapy remains to be established. This study evaluated the efficacy and safety of the venetoclax-homoharringtonine-cytarabine (VHA)… read more here.
Keywords: newly diagnosed; aml; efficacy; homoharringtonine cytarabine ... See more keywords